Back to all news
LSTM Deep Learning Enhances Optical Sensing for Biochemical and Medical Applications
Researchers have developed an LSTM-driven interferometric sensing system that achieves both high sensitivity and wide measurement range, overcoming previous trade-offs in optical sensing.
Key Details
- 1The LSTM model allows for accurate refractive index measurement beyond the free spectral range (FSR) limitation in optical interferometers.
- 2System architecture includes broadband light source, specially fabricated single-mode fiber, and spectral analyzer.
- 3Deep learning enables direct mapping of complex spectra to target measurements despite spectral overlap, tripling the detection range while retaining sensitivity.
- 4Efficient down-sampling reduces data acquisition and processing, making rapid, practical deployment feasible.
- 5Application relevance spans physics, chemistry, biology, and medicine—enabling real-time, high-precision monitoring in complex environments.
Why It Matters
This breakthrough demonstrates how advanced AI models like LSTM can significantly improve the capabilities of optical sensors used in medical and biochemical environments, potentially influencing future noninvasive diagnostic technologies. It highlights a practical pathway for AI-powered, high-precision sensing systems in challenging measurement scenarios.
Source
EurekAlert
Related News
•EurekAlert
NYU AI Model Improves 5-Year Breast Cancer Risk Prediction via 3D Mammograms
NYU researchers developed an AI model using longitudinal 3D mammograms that outperforms single-scan and 2D-based tools in predicting 5-year breast cancer risk.
•EurekAlert
AI Framework Accelerates Aortic Aneurysm Risk Prediction from Imaging
Researchers developed BioPINN-LM, combining physics-informed neural networks and multimodal large language models to deliver fast, interpretable risk assessments for ascending thoracic aortic aneurysms.
•EurekAlert
Study Finds Patient Voices Missing in Generative AI Design for Oncology
A Flinders University-led review found patients and carers are rarely involved in shaping generative AI tools used in oncology.